Hitech Urology Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-01-2025
- Paid Up Capital ₹ 0.50 M
as on 11-01-2025
- Company Age 29 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.90 M
as on 11-01-2025
- Revenue -62.09%
(FY 2020)
- Profit -167.29%
(FY 2020)
- Net Worth -3.48%
(FY 2020)
- Total Assets -18.25%
(FY 2020)
About Hitech Urology
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.90 M.
Sanjeev Kanitkar, Milind Bapat, Laxmikant Shah, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85110MH1995PTC094124
- Company No.
094124
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Nov 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hitech Urology?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Kanitkar  | Director | 02-Nov-1995 | Current |
| Milind Bapat | Director | 02-Nov-1995 | Current |
| Laxmikant Shah | Director | 02-Nov-1995 | Current |
| Sanjay Kulkarni | Director | 02-Nov-1995 | Current |
| Deepak Kirpekar | Director | 02-Nov-1995 | Current |
Financial Performance of Hitech Urology.
Hitech Urology Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 62.09% decrease. The company also saw a substantial fall in profitability, with a 167.29% decrease in profit. The company's net worth dipped by a decrease of 3.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Hitech Urology?
In 2020, Hitech Urology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kulkarni Uro-Surgery Institute Private LimitedActive 9 years 13 daysSanjay Kulkarni is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Sangli Bank Ltd. Creation Date: 16 Jan 1998 | ₹0.40 M | Open |
The Sangli Bank Ltd. Creation Date: 02 Dec 1995 | ₹0.50 M | Open |
How Many Employees Work at Hitech Urology?
Unlock and access historical data on people associated with Hitech Urology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hitech Urology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hitech Urology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
